Antinuclear Antibody Testing Market: By Product Type (Reagents & Assay Kits, Systems, and Software & Services), By Technique Type (ELISA, Immunofluorescence Assay, and Multiplex Assay), By Application (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjogren's Syndrome, Scleroderma, and Others), By End Users (Hospitals, Clinical Laboratories, Physician Office Laboratories, and Others), And Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Antinuclear Antibody Testing Market size was valued at USD 482.7 million in 2022 and is expected to grow at a CAGR of 14.1% from 2023-2029. Antinuclear antibody (ANA) testing is done to check whether there are any autoimmune disorders that disturb the body's organs and tissues. These examinations search for antinuclear antibodies in the blood serum. The human immune system develops antibodies against foreign attackers like bacteria and viruses. However, an antinuclear antibody attacks the normal cells of the patient and causes autoimmune disease. Some of the most common approaches to diagnose the occurrence of antinuclear antibodies in diseased patients are ELISA and indirect immunofluorescence. The screening test helps to check whether the body has these antibodies or not. The growing prevalence of autoimmune diseases among individuals across the world can lead to the growth of the antinuclear antibody testing market. Moreover, the increasing use of antinuclear antibody tests to diagnose autoimmune diseases such as Systemic Lupus Erythematosus, rheumatoid arthritis, Sjogren's Syndrome, and many more are some primary factors that can boost the global antinuclear antibody testing market growth. However, some factors, such as stringent U.S. Food and Drugs Administration rules for approval of the product, the absence of skilled laboratory technicians, and diagnostic mistakes, can restrain the growth of the market. Also, despite being a susceptible diagnostic tool, the anti-nuclear antibody test absences specificity, which may restrict its commercial growth soon, which can hinder the market growth. The rising number of diagnostic laboratories, accompanied by growing investments in lab automation, can create an opportunity to grow the global antinuclear antibody testing market. Moreover, changing lifestyles and eating habits have led to an increase in autoimmune diseases can further provide a lucrative opportunity for market growth.  

Antinuclear Antibody Testing Market Key Developments:
  • In November 2021, Stewart and Judy Colton from Colton Center for Autoimmunity in Pennsylvania donated US$10 million to the Perelman School of Medicine at the University of Pennsylvania to enhance the ongoing autoimmune research and care.
  • In October 2020, Johnson & Johnson acquired Momenta to grow its concentration on autoimmune diseases.

Antinuclear Antibody Testing Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

14.1%

Largest Market

Asia Pacific

Fastest Growing Market

North America
Antinuclear Antibody Testing Market Dynamics

One of the major reasons for the growth of the global antinuclear antibody testing market share is the growing cases of autoimmune diseases across the world. According to medical experts, the reason for the start of autoimmune disease is unidentified. Individual own genes joined with infection or environmental might be the cause of the autoimmune disorder. In an autoimmune disorder, the immune system of the body attacks its healthy cells. The conditions comprise type 1 diabetes, rheumatoid arthritis, multiple sclerosis, lupus, Crohn’s disease, scleroderma and psoriasis. Lifestyle changes and eating are related to increased frequencies of autoimmune diseases across the world.

Antinuclear Antibody Testing Market Segmentation

By Product Type
  • Reagents & Assay Kits
  • Systems
  • Software & Services
By Technique Type
  • ELISA
  • Immunofluorescence Assay
  • Multiplex Assay
By Application
  • Rheumatoid Arthritis
  • Systemic Lupus Erythematosus
  • Sjogren’s Syndrome
  • Scleroderma
  • Others
By End User
  • Hospitals
  • Clinical Laboratories
  • Physician Office Laboratories
  • Others

Frequently Asked Questions

The antinuclear antibody testing market is projected to expand at a CAGR of 14.1% during the forecast period.  

Bio-Rad Laboratories, Inc, Immuno Concepts NA Ltd, Inova Diagnostics, Inc, ZEUS Scientific, Inc, Alere Inc.

North America is the fastest-growing region for the antinuclear antibody testing market

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
1. Executive Summary
2. Global Antinuclear Antibody Testing Market Introduction
2.1. Global Antinuclear Antibody Testing Market Taxonomy
2.2. Global Antinuclear Antibody Testing Market Definitions
2.2.1. Product Type
2.2.2. Technique
2.2.3. Application
2.2.4. End User
2.2.5. By Region
3. Global Antinuclear Antibody Testing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Antinuclear Antibody Testing Market Dynamic Factors - Impact Analysis
3.6. Global Antinuclear Antibody Testing Market Competition Landscape
4. Global Antinuclear Antibody Testing Market, By Product Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
4.1. Reagents & Assay Kits
4.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
4.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.1.3. Market Opportunity Analysis
4.2. Systems
4.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
4.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.2.3. Market Opportunity Analysis
4.3. Software & Services
4.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
4.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.3.3. Market Opportunity Analysis
5. Global Antinuclear Antibody Testing Market, By Technique, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1. ELISA
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Immunofluorescence Assay
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Multiplex Assay
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Antinuclear Antibody Testing Market, By Application, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.1. Rheumatoid Arthritis
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Systemic Lupus Erythematosus
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Sjogren’s Syndrome
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Scleroderma
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Others
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. Global Antinuclear Antibody Testing Market, By End User, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.1. Hospitals
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Clinical Laboratories
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Physician Office Laboratories
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Others
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
8. Global Antinuclear Antibody Testing Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Antinuclear Antibody Testing Market - Opportunity Analysis Index, By Product Type, By Technique, By Application, By End User, and Region, 2023 - 2029
9. North America Antinuclear Antibody Testing Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Reagents & Assay Kits
9.1.2. Systems
9.1.3. Software & Services
9.2. Technique Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.2.1. ELISA
9.2.2. Immunofluorescence Assay
9.2.3. Multiplex Assay
9.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.3.1. Rheumatoid Arthritis
9.3.2. Systemic Lupus Erythematosus
9.3.3. Sjogren’s Syndrome
9.3.4. Scleroderma
9.3.5. Others
9.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.4.1. Hospitals
9.4.2. Clinical Laboratories
9.4.3. Physician Office Laboratories
9.4.4. Others
9.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.5.1. USA
9.5.2. Canada
9.6. North America Antinuclear Antibody Testing Market - Opportunity Analysis Index, By Product Type, By Technique, By Application, By End User, and Country, 2023 - 2029
9.7. North America Antinuclear Antibody Testing Market Dynamics Trends
10. Europe Antinuclear Antibody Testing Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
10.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Reagents & Assay Kits
10.1.2. Systems
10.1.3. Software & Services
10.2. Technique Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. ELISA
10.2.2. Immunofluorescence Assay
10.2.3. Multiplex Assay
10.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.3.1. Rheumatoid Arthritis
10.3.2. Systemic Lupus Erythematosus
10.3.3. Sjogren’s Syndrome
10.3.4. Scleroderma
10.3.5. Others
10.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.4.1. Hospitals
10.4.2. Clinical Laboratories
10.4.3. Physician Office Laboratories
10.4.4. Others
10.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. Germany
10.5.2. UK
10.5.3. France
10.5.4. Spain
10.5.5. Italy
10.5.6. Rest of Europe
10.6. Europe Antinuclear Antibody Testing Market - Opportunity Analysis Index, By Product Type, By Technique, By Application, By End User, and Country, 2023 - 2029
10.7. Europe Antinuclear Antibody Testing Market Dynamics Trends
11. Asia-Pacific Antinuclear Antibody Testing Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
11.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Reagents & Assay Kits
11.1.2. Systems
11.1.3. Software & Services
11.2. Technique Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. ELISA
11.2.2. Immunofluorescence Assay
11.2.3. Multiplex Assay
11.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.3.1. Rheumatoid Arthritis
11.3.2. Systemic Lupus Erythematosus
11.3.3. Sjogren’s Syndrome
11.3.4. Scleroderma
11.3.5. Others
11.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.4.1. Hospitals
11.4.2. Clinical Laboratories
11.4.3. Physician Office Laboratories
11.4.4. Others
11.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. China
11.5.2. India
11.5.3. Japan
11.5.4. ASEAN
11.5.5. Australia & New Zealand
11.5.6. Rest of Asia-Pacific
11.6. Asia-Pacific Antinuclear Antibody Testing Market - Opportunity Analysis Index, By Product Type, By Technique, By Application, By End User, and Country, 2023 - 2029
11.7. Asia-Pacific Antinuclear Antibody Testing Market Dynamics Trends
12. Latin America Antinuclear Antibody Testing Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
12.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Reagents & Assay Kits
12.1.2. Systems
12.1.3. Software & Services
12.2. Technique Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. ELISA
12.2.2. Immunofluorescence Assay
12.2.3. Multiplex Assay
12.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.3.1. Rheumatoid Arthritis
12.3.2. Systemic Lupus Erythematosus
12.3.3. Sjogren’s Syndrome
12.3.4. Scleroderma
12.3.5. Others
12.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.4.1. Hospitals
12.4.2. Clinical Laboratories
12.4.3. Physician Office Laboratories
12.4.4. Others
12.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Latin America Antinuclear Antibody Testing Market - Opportunity Analysis Index, By Product Type, By Technique, By Application, By End User, and Country, 2023 - 2029
12.7. Latin America Antinuclear Antibody Testing Market Dynamics Trends
13. Middle East and Africa Antinuclear Antibody Testing Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
13.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Reagents & Assay Kits
13.1.2. Systems
13.1.3. Software & Services
13.2. Technique Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. ELISA
13.2.2. Immunofluorescence Assay
13.2.3. Multiplex Assay
13.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.3.1. Rheumatoid Arthritis
13.3.2. Systemic Lupus Erythematosus
13.3.3. Sjogren’s Syndrome
13.3.4. Scleroderma
13.3.5. Others
13.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.4.1. Hospitals
13.4.2. Clinical Laboratories
13.4.3. Physician Office Laboratories
13.4.4. Others
13.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Gulf Cooperation Council (GCC) Countries
13.5.2. South Africa
13.5.3. Rest of MEA
13.6. MEA Antinuclear Antibody Testing Market- Opportunity Analysis Index, By Product Type, By Technique, By Application, By End User, and Country, 2023 - 2029
13.7. MEA Antinuclear Antibody Testing Market Dynamics Trends
14. Competition Landscape
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Key Product Types, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Bio-Rad Laboratories, Inc.
14.2.2. Trinity Biotech Plc.
14.2.3. Thermo Fisher Scientific
14.2.4. Antibodies Incorporated
14.2.5. EUROIMMUN Medizinische Labordiagnostika AG
14.2.6. Immuno Concepts NA Ltd.
14.2.7. Inova Diagnostics, Inc.
14.2.8. ZEUS Scientific, Inc.
14.2.9. Alere Inc.
15. Research Methodology
16. Key Assumptions and Acronyms
  • Bio-Rad Laboratories, Inc.
  • Trinity Biotech Plc.
  • Thermo Fisher Scientific
  • Antibodies Incorporated
  • EUROIMMUN Medizinische Labordiagnostika AG
  • Immuno Concepts NA Ltd.
  • Inova Diagnostics, Inc.
  • ZEUS Scientific, Inc.
  • Alere Inc.

Adjacent Markets